Nirsevimab Administration During the Birth Hospitalization
- Shayda Daneshvari; Philip Lee; Sheri Nemerofsky
Access Resources
About
This brief report describes a study focused on the birth hospital nirsevimab administration rate and compared it to the hepatitis B vaccine rate in the same institution. The study included newborns discharged between December 1, 2023, and March 31, 2024, from a medical center in Bronx, NY. Data on birthing parent and newborn characteristics were analyzed. Statistical tests were conducted to compare immunization rates.
Tags
More like this
The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.